7.2 Medication Boundary

Medications can alter glucose, insulin, appetite, water, electrolytes, weight, and energy outputs.

With glucose-lowering drugs, insulin, diuretics, or hormone medications, ordinary Human FBM interpretation cannot be applied directly.

Medication class determines which metabolic variables are affected.

Dose and duration determine output-change amplitude.

Polypharmacy increases interpretation uncertainty.

Monitoring markers and clinical symptoms must be read separately from structural variables.

After medication introduction, substrate-structure variables and medication variables change together, increasing causal complexity.

Before medication plan is medically adjusted, diet-structure change should not be treated as the only explanatory path.

Common outputs include glucose volatility, weight change, appetite change, electrolyte-related expression, and energy-state shifts.

These outputs require joint interpretation with medication and clinical variables, not attribution to fatty-acid structure alone.

Medically supervised medication contexts cannot be overridden by diet architecture alone.

This page defines judgment boundaries only and provides no medication advice.